Found 0 matching trials
A Phase 1B Investigator Initiated Study of Safety and Tolerability of Dexamethasone (D) in Combination With Venetoclax-based Low-Intensity Therapy (LIT) in Treatment-Naïve Acute Myeloid Leukemia (AML): DLIT-AML PHASE1 This study is investigating whether adding dexamethasone, an anti-inflammat...
Show More Status
Enrolling By Invitation
Location
University of Vermont Medical Center
Learn More & Join Trial
Decitabine Plus mBU/CY Preconditioning for Relapse/Refractory Acute Leukemia PHASE2 Allogeneic haematopoietic stem cell transplantation (allo-HSCT) remains one...
Show More Location
Peking University Institute of Hematology,Beijing
Learn More & Join Trial
Venetoclax, Azacitidine and Liposomal Mitoxantrone for Newly Diagnosed AML NA This is a single-arm, open-label clinical trial evaluating the safety and p...
Show More Location
Blood diseases hospital
Learn More & Join Trial
Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer PHASE1 The goal of this clinical research study is to find out if giving azacitidi...
Show More Location
UT MD Anderson Cancer Center
Learn More & Join Trial
Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML PHASE2 To compare the efficacy and safty of ABC-14 regimen with the traditional "3...
Show More Location
Dongguan General Hosptial
Learn More & Join Trial
Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia PHASE2 This randomized phase II trial studies azacitidine with or without entinost...
Show More Location
Mayo Clinic in Arizona
Learn More & Join Trial
A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax PHASE1 The purpose of this research study is to test the safety and efficacy of a ...
Show More Location
Brigham and Women's Hospital
Learn More & Join Trial
Olutasidenib in Relapsed IDH1 Mutated AML Patients Who Have Previously Received Venetoclax PHASE2 This is a prospective, single-arm phase 2 pilot study to assess the respons...
Show More Location
Atrium Health Wake Forest Baptist Medical Center
Learn More & Join Trial
Azacitidine and Cisplatin for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck PHASE1 To evaluate the safety and toxicity of azacitidine (5-azacitidine, Vidaza®)...
Show More Location
Kansas City VA Medical Center
Learn More & Join Trial
Decitabine and Anti-PD-1 in R/R DLBCL PHASE2 Patients with relapsed/refractory diffuse large B cell lymphoma with extran...
Show More Learn More & Join Trial